JE 2147
Alternative Names: AG 1776; KNI 764Latest Information Update: 26 Sep 2003
At a glance
- Originator Japan Energy Corporation
- Class Antivirals; Dipeptides
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 26 Sep 2003 Discontinued - Phase-I for HIV infections treatment in USA (unspecified route)
- 22 Jun 2000 Warner-Lambert has merged with Pfizer
- 01 Dec 1999 Phase-I clinical trials for HIV infections treatment in USA (Unknown route)